Analysis of the inhibiting activity of presynaptic $$\alpha _{2^ - } ADRENOCEPTORS$$ against NSAID-induced gastric mucosal lesions in the ratagainst NSAID-induced gastric mucosal lesions in the rat

[1]  M. Andréjak,et al.  Effects of some α-adrenoceptor agonists and antagonists on the guinea-pig ileum , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  J. Mikulicz-Radecki,et al.  Der Einfluß von 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorid (Catapresan®) auf die Funktion von Magen und Pankreas , 1971, European Journal of Clinical Pharmacology.

[3]  G. Lazzeri,et al.  Characterization of α2-adrenoceptor subtypes involved in the modulation of gastric acid secretion , 1995 .

[4]  E. Vizi,et al.  Functional evidence that [3H]acetylcholine and [3H]noradrenaline release from guinea pig ileal myenteric plexus and noradrenergic terminals is modulated by different presynaptic alpha-2 adrenoceptor subtypes. , 1993, The Journal of pharmacology and experimental therapeutics.

[5]  A. Rémaury,et al.  The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. , 1992, The Journal of pharmacology and experimental therapeutics.

[6]  D. Bylund,et al.  Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. , 1991, The Journal of pharmacology and experimental therapeutics.

[7]  P. Rataboli,et al.  Dual action of clonidine on ethanol-induced gastric lesions: is the imidazoline-preferring receptor involved? , 1991, European journal of pharmacology.

[8]  K. Gyires.  Morphine inhibits the ethanol-induced gastric damage in rats. , 1990, Archives internationales de pharmacodynamie et de therapie.

[9]  D. Bylund.  Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence converg , 1988 .

[10]  C. Blandizzi,et al.  Excitatory and inhibitory cholinergic effects of yohimbine on isolated guinea-pig small intestine. , 1988, Pharmacological research communications.

[11]  J. Dijoseph,et al.  Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity. , 1987, The Journal of pharmacology and experimental therapeutics.

[12]  E. Vizi,et al.  CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. , 1986, The Journal of pharmacology and experimental therapeutics.

[13]  P. Soldato.  Gastric Lesion-Preventing or -Potentiating Activity of Clonidine in Rats , 1986 .

[14]  S. Kulkarni,et al.  Effect of alpha2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats. , 1985, Archives internationales de pharmacodynamie et de therapie.

[15]  M. Impicciatore,et al.  Pharmacological studies on the mechanisms underlying the inhibitory and excitatory effects of clonidine on gastric acid secretion. , 1982, European journal of pharmacology.

[16]  G. N. Mir,et al.  Alpha adrenergic receptors and gastric function , 1982 .

[17]  H. Cheng,et al.  Effects of clonidine on gastric acid secretion in the rat. , 1981, The Journal of pharmacology and experimental therapeutics.

[18]  M. Andréjak,et al.  Effects of some alpha-adrenoceptor agonists and antagonists on the guinea-pig ileum. , 1980, Naunyn-Schmiedeberg's archives of pharmacology.

[19]  S. Gershon,et al.  Pharmacological and biochemical properties of isomeric yohimbine alkaloids. , 1978, European journal of pharmacology.

[20]  H. Shay,et al.  A quantitative method for measuring spontaneous gastric secretion in the rat. , 1954, Gastroenterology.